GlassScriptPhysician profile
Malick Gazabfar Islam
NPI 1265663124
$11,263.83
in general payments reported to CMS, 2019-2025
27 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,965 · 2020: $2,249 · 2021: $1,086 · 2022: $3,534 · 2023: $1,635 · 2024: $613 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.82 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,256.10 | 2019-2025 | Assurity, Ensite Precision, Ensite |
| Medtronic Vascular, INC. | $2,221.26 | 2019-2020 | |
| Boston Scientific Corporation | $1,275.01 | 2019-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $949.33 | 2021-2024 | Micra, Azure Xt Dr Mri Surescan, Arctic Front Advance |
| Biosense Webster, INC. | $620.32 | 2021-2023 | Carto 3, Smartablate, Octaray Mapping Catheter |
| Cardiovascular Systems INC. | $459.55 | 2019-2020 | |
| Cook Medical LLC | $282.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $125.66 | 2019-2020 | |
| Amgen INC. | $123.72 | 2019-2020 | |
| Biotronik INC. | $108.42 | 2021-2022 | |
| Bardy Diagnostics, INC. | $104.92 | 2020 | |
| Inari Medical, INC. | $63.90 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $61.37 | 2020-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $59.00 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $57.33 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $43.52 | 2019-2020 | |
| Pfizer INC. | $42.77 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $30.02 | 2019 | |
| Lundbeck LLC | $25.75 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.47 | 2019-2020 | |
| Akcea Therapeutics, INC. | $19.17 | 2020 | |
| Stryker Corporation | $16.86 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $15.27 | 2019 | |
| Preventice Services, LLC | $13.72 | 2019 | |
| Ekos Corporation | $12.42 | 2019 | |
| Infobionic, INC | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malick Islam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.